Catalent Pharma Solutions LLC

Form 483 issued December 15, 2022 · Morrisville, North Carolina

Inspection
Dec 5 – Dec 15, 2022
Observations
4
Pages
6
FEI number
1000110912

In short: On December 15, 2022, FDA issued a Form 483 with 4 observations to Catalent Pharma Solutions LLC in Morrisville, North Carolina (FEI 1000110912) after an inspection that ran Dec 5 – Dec 15, 2022. The investigator was Philip F. Istafanos. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

4 of 4 observations on this 483 concern laboratory controls.

Laboratory controls4

What FDA observed

Preview: the opening words of each observation
  1. 01

    Test procedures relative to appropriate laboratory testing for…

  2. 02

    Procedures describing the calibration of instruments, apparatus, gauges and recording devices are…

  3. 03

    The accuracy of test methods…

  4. 04

    Established test procedures and laboratory control…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Catalent Pharma Solutions LLC?

FDA listed 4 observations on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Catalent Pharma Solutions LLC?

Philip F. Istafanos is named on this Form 483, for the inspection of Dec 5 – Dec 15, 2022. Each investigator has a profile showing what they cite most.

When was Catalent Pharma Solutions LLC inspected by FDA?

The inspection ran Dec 5 – Dec 15, 2022, and the Form 483 is dated December 15, 2022.

How do I get the full Form 483 for Catalent Pharma Solutions LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free